Drug – bio-affecting and body treating compositions – Preparations characterized by special physical form – Matrices
Reexamination Certificate
2006-06-13
2006-06-13
Azpuru, Carlos A. (Department: 1615)
Drug, bio-affecting and body treating compositions
Preparations characterized by special physical form
Matrices
C424S078040
Reexamination Certificate
active
07060297
ABSTRACT:
Disclosed are carrageenan-based transitional viscoelastics that will induce little or no IOP spike when left in the eye at the close of surgery thereon. Drug delivery systems for delivering therapeutic agents during post-operative recovery stages are also disclosed.
REFERENCES:
patent: 4328803 (1982-05-01), Pape
patent: 5273056 (1993-12-01), McLaughlin et al.
patent: 5403841 (1995-04-01), Lang et al.
patent: 5466461 (1995-11-01), della Valle et al.
patent: 5616568 (1997-04-01), Pouyani et al.
patent: 5618800 (1997-04-01), Kabra et al.
patent: 5652347 (1997-07-01), Pouyani et al.
patent: 5792103 (1998-08-01), Schwartz et al.
patent: 5811453 (1998-09-01), Yanni et al.
patent: 5851229 (1998-12-01), Lentz et al.
patent: 5965152 (1999-10-01), Galin et al.
patent: 5972326 (1999-10-01), Galin et al.
patent: 6177544 (2001-01-01), Kanai et al.
patent: 6261547 (2001-07-01), Bawa et al.
patent: 0 271 131 (1988-06-01), None
patent: 0 424 043 (1991-04-01), None
patent: 0271131 (1999-10-01), None
patent: 2 698 264 (1994-05-01), None
patent: WO 99/58160 (1999-11-01), None
patent: WO 00/01733 (2000-01-01), None
Berson et al., “Obstruction of Aqueous Outflow by Sodium Hyaluronate in Enucleated Human Eyes,”Am. J. Ophthalmology,95:668 (1983).
Bulpitt and Aeschlimann “New strategy for chemical modification of hyaluronic acid: Preparation of functionalized derivatives and their use in the formation of novel biocompatible hydrogels,”Biomed. Mater. Res., 47:152-169 (1999).
Carlsson et al., “Thermal Gelation of Nonionic Cellulose Ethers and Ionic Surfactants in Water”Colloids Surf., 47:147-65 (1990).
Danishefsky and Siskovic,“Conversion of Carboxyl Groups of Mucopolysaccharides in Amides of Amino Acid Esters,”Carbohydrate Res., 16:199-205 (1971).
Fry, “Postoperative intraocular pressure rises : A comparison of Healon, Amvis, and Viscoat,”J. Cataract Refractive Surgery,15:415 (1989).
Greaves et al., “Scintigraphic Assessment of an Ophthalmic Gelling Vehicle in Man and Rabbit,”Curr. Eye Res., 9:415 (1990).
Gurney et al., “The Development and Use ofIn SituFormed Gels, Triggered by pH,”Biopharm. Ocul. Drug Delivery,pp. 81-90 (1993).
Obstbaum, “Postoperative pressure elevation. A rational approach to its prevention and management,”J. Cataract Refractive Surgery,81:1 (1992).
Olivius et al., “Intraocular pressure after cataract surgery with Healon®,”Am. Intraocular Implant Soc. J., 11:480 (1985).
Picullel et al., “Gelling Carrageenans,” Food Polysaccharides and Their Applications, Ed: Stephen, A.M., Marcel Dekker:New York, vol. 67, pp. 204-244 (1995).
Rozier et al., “Gelrite: A Novel, Ion-Activated,In SituGelling Polymer for Ophthalmic Vehicles. Effect on Bioavailability of Timolol,”Int. J. Pharm., 57:163 (1989).
Verschueren et al., “Evaluation of various carrageenans as ophthalmic viscolysers,” STP Pharma Sci, 6:203-210 (1996).
Brunstedt Michael R.
Karakelle Mutlu
Alcon Inc.
Armando Pastrana, Jr.
Azpuru Carlos A.
LandOfFree
Carrageenan viscoelastics for ocular surgery does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Carrageenan viscoelastics for ocular surgery, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Carrageenan viscoelastics for ocular surgery will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3623977